Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201110130 Principal Investigator: Van Tine, Brian
Title: A randomized, multicenter, double-blind, phase II trial of KLH conjugated trivalent ganglioside vaccine containing GM2, GD2 Lactone and GD3 Lactone with immunological adjuvant OPT-821 vs. OPT-821 alone in metastatic sarcoma patients who are rendered disease free
Phase: II Disease Site: Soft Tissue
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to compare the effects, good and/or bad, that the vaccine with OPT-821 or OPT-821 alone has on patients and their cancer.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)